Viatris Will Tread A Different Path
Mylan-Upjohn Combination Neither Pure Generics Nor Big Pharma Player
• By Aidan Fry
The Viatris entity formed by merging Mylan and Upjohn will aim to chart a path between generics and big pharma • Source: Shutterstock 
